<DOC>
	<DOCNO>NCT02790801</DOCNO>
	<brief_summary>The purpose study evaluate management chronic heart failure patient atrial fibrillation , collect data compliance clinical guideline prevalence long-term anticoagulant therapy , complication . The result use develop rational therapeutic diagnostic strategy improve clinical outcome patient .</brief_summary>
	<brief_title>The First Russian Observational Survey Heart Failure Patients With Atrial Fibrillation</brief_title>
	<detailed_description>Quality assurance plan : investigator go plan site monitoring every three month . Any audit plan Investigatirs check enter data registry predefined range . The database protect inconsistency incorrect enter strictly predefined range field . Instead , data check perform yearly . During site monitoring data verification transfer source document database perform . Iiverstigators data dictionary , include description variable , relevant , normal range . Investigators use standard local operation procedure activity registry ( patient recruitment , data collection management , data analysis ) local authority approve procedure . Investigators calculate sample size demonstration hypothesis registry . Descriptive analysis data report use basic summary statistic . Results summarize whole group diagnostic subgroup . P-values confidence interval 2-sided , statistical significance declare 2-sided 0,05-level . For continuous variable mean value , standard deviation , 95 % confidence interval , median low upper percentile , well minimum maximum value calculate . Safety assess report AEs relation , seriousness , action take , outcome . AEs summarize use MedDRA cod system . Event rate single AEs calculate base total number document patient . AEs categorize accord relation , seriousness outcome .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>patient symptomatic chronic heart failure diagnose 3 month enrol , ejection fraction leave ventricular &gt; 40 % N terminalproBtype natriuretic peptide ≥300 pg/ml Btype natriuretic peptide ≥100 pg/ml . patient nonvalvular stable atrial fibrillation transient ischemic attack within 3 day inclusion , stroke 14 day inclusion , myocardial infarction within 14 day inclusion , thromboembolic complication thrombosis within 14 day inclusion , heart failure valvular pathology , heart failure induce infection agent infiltrative disease , alcohol consumption , use psychoactive drug ; peripartal heart failure ; transient condition plan heart transplantation implantation biventricular pacemaker within 28 day inclusion severe condition limit life le 3 month HIV infection Alcohol consumption psychoactive drug intake participation experimental study within 30 day inclusion patient ready contact telephone end study screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>chronic heart failure</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>anticoagulant</keyword>
</DOC>